Summary
This business focuses on developing precision brain stimulation therapies aimed at treating memory loss caused by traumatic brain injury and degenerative diseases such as Alzheimer's. Their technology, developed at a prestigious university with government funding, utilizes artificial intelligence to monitor brain activity and deliver targeted stimulation to enhance memory performance. The company is currently in the preclinical testing phase and plans to seek FDA approval for clinical trials.
Based on content on niatherapeutics.com
No similar companies found
We offer API access to our data.
8 of 8 checks passed
Label
Value
Active Dates
6.9 years — Since Feb 2018
Web Hosting
Platform
E-Mail Provider
Google GSuite
NAICS Code
621511
SIC 4 Digit Code
8093
SIC 2 Digit Code
80
Industry
1. Healthcare technology specializing in neurological treatments.
2. Medical Laboratories
Vendor
Source
TXT Record
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 |
|
|
|
|
|
|
|
|
|
|
|
|